Cargando…
A Case of Rivaroxaban Associated Intracranial Hemorrhage
Rivaroxaban is a newer anticoagulant initially approved by the Food and Drug Administration to treat nonvalvular atrial fibrillation. Rivaroxaban has several characteristics that are more favorable than warfarin. One of the characteristics is decreased risk of hemorrhage. We report one of the first...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Department of Emergency Medicine, University of California, Irvine School of Medicine
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100836/ https://www.ncbi.nlm.nih.gov/pubmed/25035736 http://dx.doi.org/10.5811/westjem.2014.2.19440 |